Post Details
https://www.einnews.com/pr_news/591677963/pneumococcal-vaccine-market-to-see-y-o-y-growth-of-5-witnessing-growth-and-value
Growing incidence of pneumonia globally, increased government focus on immunization programs for pneumonia, and rise in focus for new pneumococcal vaccines propel the market growth. However, longer timelines required for pneumonia vaccine production and high cost associated with the development of such vaccines restrain the growth of the market. Conversely, the development of protein-based combination pneumococcal vaccines creates new opportunities for the growth of the market. According to the report, the global pneumonia vaccines market generated $7.08 billion in 2017, and is expected to reach $10.21 billion by 2025, growing at a CAGR of 5% from 2018 to 2025.
27-Sep-2022, 04:07 PM